#38 Psychedelic Insights Part 5: Jeffrey Guss – Psychedelic assisted therapy & therapeutic potentials
In this episode you will meet, medical doctor, psychiatrist, psychoanalyst, researcher, and teacher, Jeffrey Guss. Guss was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psilocybin-assisted psychotherapy in the treatment of cancer related existential distress. He is currently a Lead Trainer with Fluence, with a focus on the integration of psychedelic therapy with psychoanalysis. Furthermore, Guss is a study therapist in the NYU study on Psilocybin-Assisted treatment of Major Depressive Disorder, and he has published on the integration of ACT - Acceptance and Commitment Therapy - with psychedelic assisted therapy. In this podcast, which was recorded through Zoom a few weeks after the conference, we talk with Guss about the broad therapeutic applications of psychedelic substances, and based on his research, Guss offers some insights into some of the psychological mechanisms that seem to impact this broad potential.We hope you will enjoy the conversation!Resources:Find out more about Guss’ work and publications hereOpen Source study on psilocybin-assisted psychotherapy in the treatment of cancer related existential distress:https://pubmed-ncbi-nlm-nih-gov.ep.fjernadgang.kb.dk/27909164/Host: Sidsel MarieProduction: Heine VolderMusic: Victor LangeThis podcast was made in a collaboration between Regnfang and Cepda - the Danish Center for Psychedelic Awareness.The music in the podcast was made by Victor Lange.Thank you to the OPEN Foundation for organizing and funding the ICPR conference and for providing us a quiet space during the conference for doing the podcast recordings.Illustrations by Lizette RosagerFollow the links to learn more about Cepda and Regnfang